IP Library › Granted Patent US 9,789,177
Granted Patent B2
US 9,789,177 · App. 14/311,944 · Granted Oct 17, 2017

Immunogenic protein Pas n 1 from Bahia grass pollen

Inventors: Robyn O'Hehir (Melbourne, AU); Janet Davies (Woolloongabba, AU); Jennifer Rolland (Melbourne, AU)
Assignee: Queensland University of Technology
A61K39/35C07K14/415C07K16/16G01N33/577
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,789,177
App. No.
14/311,944
Granted
Oct 17, 2017
Kind
B2
Abstract

The present invention relates generally to novel recombinant polypeptides of Bahia grass pollen and to genetic sequences encoding same. More particularly, the present invention is directed to Pas n 1 polypeptides and derivatives, and fragments thereof and genetic sequences encoding same. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications including, but not limited to, applications in the context of conditions characterized by an aberrant, inappropriate or otherwise unwanted immune response to the Bahia grass pollen.

Claims (7)

1. A pharmaceutical composition comprising an effective amount of a non-glycosylated polypeptide that comprises the amino acid sequence as set forth in SEQ ID NO: 4, or an amino acid sequence having at least 95%, 96%, 97%, 98% or 99% or more sequence identity to the entire amino acid sequence of SEQ ID NO: 4; and an acceptable carrier and/or diluent.

2. A method for the treatment and/or of a grass pollen hypersensitivity in a mammal said method comprising administering to said mammal a pharmaceutical composition comprising an effective amount of a non-glycosylated polypeptide that comprises the amino acid sequence set forth in SEQ ID NO:4, or an amino acid sequence having at least 95%, 96%, 97%, 98% or 99% or more sequence identity to the entire amino acid sequence of SEQ ID NO:4; and an acceptable carrier and/or diluent.

3. The method according to claim 2 wherein said mammal is treated for a condition characterized by an aberrant, unwanted or otherwise inappropriate immune response to Pas n 1.

4. The method according to claim 3 wherein said condition is Bahia grass pollen hypersensitivity.

5. The method according to claim 4 wherein said condition is hypersensitivity to the pollen of grasses of the family Pancoideae or Pooideae.

6. The method according to claim 5 wherein said grass is Timothy, Bermuda or Rye.

7. The method according to claim 6 wherein said polypeptide is administered in combination with one or more Group 1 pollen allergens from other grass pollens.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2016
From: UNIQUEST PTY LIMITED
To: QUEENSLAND UNIVERSITY OF TECHNOLOGY
Reel/Frame 039717/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2015
From: O'HEHIR, ROBYN; DAVIES, JANET; ROLLAND, JENNIFER
To: THE UNIVERSITY OF QUEENSLAND
Reel/Frame 035863/0842 →
Priority Claims (2)
AU 2007905753 · Oct 22, 2007 · national
AU 2008901357 · Mar 19, 2008 · national
Continuity (2)
Division 12738618
Related Publication 20140302073A1 · Oct 9, 2014